Speakers confirmed so far
- Roel Nusse - Stanford University - Wnt/beta-catenin signalling pathway
- Alexandra Newton - University of California, San Diego - PKB signalling
- Chris Proud - University of British Columbia, Vancouver - mTOR signalling
- Wayne Phillips - Peter MacCallum Cancer Inst, Melbourne- PI 3-kinase in cancer
- Bill Denny - University of Auckland - Cancer drug discovery
- Margaret Hibbs - Ludwig Cancer institute, Melbourne - Src tyrosine kinases
- Terry Mulhern - Bio21 Melbourne - Structural biology of signalling molecules
- Aimin Xu - University of Hong Kong - Adiponectin Signalling
- John Whitehead - University of Queensland - Adipokine signalling
- Dr Helena Richardson - Peter MacCallum Research Institute, Melbourne - Cell Cycle Signalling
- Dr Andrew Wilkes - Cytopia, Melbourne - Development of drugs targeting the JAK/STAT signalling pathway
- Jonathan Backer - Albert Einstein College of medicine, New York - PI 3-kinase signalling
- David James - Garvan Institute, Sydney - Insulin Signalling
- Richard Newcomb - Hortresearch - GPCR signalling
- Guy Salveson - Burnham Institute, San Diego - Signalling to Apoptosis
- Stuart Pitson - Hanson Institute, Adelaide - Sphingosine Kinase signalling
- Dave Carling - Imperial College London - AMP-Kinase Signalling
- Mark Febbraio - Baker Institute, Melbourne - Cytokine Signalling
- Dave Grattan - University of Otago - Leptin and Insulin signalling in the brain
- Claire Chaussade - University of Auckland - PI 3-kinase signalling
- Roger Bosse - Perkin Elmer - Alpha screen technology
- Debbie Hay - University of Auckland - CGRP signalling
- Emma Kay - University of Auckland - Regulation of GPCR's by mRAP
- Mark Hampton - Christchurch Clinical School, Univ of Otago - Redox Signaling
- Patrick Sexton - Monash University, Melbourne
- Frank Cooke - University College London - PIKfyve signaling
- Andrew Dingley - University of Auckland - Structure Function of IL6 Signalling
- John Hancock - Texas Health Science Center - Ras Signalling
|
Sponsors
|
